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Abstract: The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) β has an essential function in dendritic 
spines via binding to and reorganization of the actin cytoskeleton during plasticity events not shared by CaMKIIα 
isoform. CaMKIIβ and CaMKIIα isoforms have remarkable structural differences within the variable region. Three 
exons (E1, E3, and E4) are present in CaMKIIβ but not in CaMKIIα gene. Four splice variants of CaMKIIβ isoforms 
(CaMKIIβ, β’, βe and β’e) were discovered in embryonic and adult brains. Exons E1 (lacked in βe and β’e) and E4 
(lacked in β’ and β’e) are subject to differential alternative splicing. We hypothesized that the sequences encoded 
by exons E1, E3, and/or E4 are involved in CaMKIIβ-specific bundling to the F-actin cytoskeleton. We tested the 
colocalization and association of these CaMKIIβ variants within an F-actin-rich structure (microspike) in CaMKIIα 
free embryonic day 18 (E-18) rat cortical neurons. Our results showed that CaMKIIβ and CaMKIIβ’ containing exon 
E1 displayed an association with F-actin, while CaMKIIβe and CaMKIIβ’e  lacking E1 did not. Moreover, CaMKIIβ’ 
lacking exon E4 but having E1 showed decreased actin bindingcapacity compared to WT CaMKIIβ. This suggested 
E1 is required for the association between CaMKIIβ and F-actin, while E4 assists CaMKIIβ to associate with F-actin 
better. Thus, alternative splicing of CaMKIIβ variants in developing neurons may serve as a developmental switch 
for actin cytoskeleton-associated isoforms and therefore correlated with dendritic arborization and synapse forma-
tion during LTP.
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Introduction
The plasticity of neuronal synapses is essential 
for the formation and function of neural cir-
cuits, which is fundamental to learning and 
memory. Long-term potentiation (LTP) of synap-
tic function is crucial for the process of learning 
and memory by inducing the formation of new 
dendritic spines and increasing the volume of 
existing ones [1-4]. Calcium/calmodulin depen-
dent protein kinase II (CaMKII) is a ubiquitously 
expressed serine/threonine protein kinase 
involved in a vast variety of cellular functions by 
phosphorylating a number of substrates includ-
ing several cytoskeletal and signaling proteins 
[5-7]. Interestingly, CaMKII constitutes a sub-
stantial portion, 1-2%, of the total protein con-
tent of brain [8-11]. Especially in postsynaptic 
density (PSD), the percentage of CaMKII goes 
up to 10-30% [10]. It is much more abundant 
than any other signal transduction molecules 
and is comparable to the abundance of struc-
tural proteins found in the PSD, such as actin. 
Correspondingly, in addition to its signaling 
function, CaMKII also has a structural function 
to bundle actin filaments in coupling structural 
and functional plasticity of dendritic spines, 
which plays a critical role in the molecular 
mechanisms of LTP [12].
CaMKIIα and CaMKIIβ are the two major brain 
isoforms where they make up the vast majority 
of neuronal CaMKII [8]. CaMKIIβ was reported 
to have specific morphogenic functions in regu-
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lating dendritic arborization and synapse den-
sity which are not shared by CaMKIIα isoform 
[13]. This isoform specificity is very likely to be 
mediated by the specific binding of CaMKIIβ, 
but not CaMKIIα, to filamentous actin (F-actin) 
[13, 14]. CaMKIIβ stabilizes the actin cytoskel-
eton in spines in a kinase activity independent 
manner and thereby maintains the stability of 
spine structure, while phosphorylation of 
CaMKIIβ reduces this bundling activity [15-17]. 
The most remarkable structural difference 
between CaMKIIβ and CaMKIIα isoforms is 
located within the variable region which con-
nects the kinase domain and the association 
domain [9, 18]. Three exons located in the vari-
able region of CaMKIIβ, exon 1 (E1), exon 3 
(E3), and exon 4 (E4), are not presented in the 
CaMKIIα gene (Figure 1), which leads to the 
speculation that sequences encoded by the 
exons E1, E3, and/or E4 are involved in 
CaMKIIβ-specific bundling to the F-actin cyto-
skeleton. In both embryonic and adult brains, 
Figure 1. Schematic representation of individual isoforms of CaMKII variants. CaMKIIα and CaMKIIβ differ most in 
the variable region (They are products of different genes and have minor differences in the kinase and association 
domain which are not represented in this figure). Exon/intron structures of the CaMKIIα and β gene locus coding for 
the variable regions are shown in bottom. The variable region of CaMKIIα contains only exon 2 (E2) and exon 5 (E5). 
Both of these two exons are also presented in CaMKIIβ. Exon 3 (E3) is not identified in CaMKIIα but is contained in 
all CaMKIIβ variants. In CaMKIIβ variants, WT CaMKIIβ has all five axons. CaMKIIβ’ contains exon 1 (E1), E2, E3 and 
E5, but not exon E4. While CaMKIIβe lacks E1. E1 and E4 do not present in CaMKIIβ’e. 
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four splice variants of CaMKIIβ isoforms are 
detected: wildtype (WT) CaMKIIβ, CaMKIIβ’, 
CaMKIIβe, and CaMKIIβ’e (a “e” refers to the 
embryonic form) [19]. Exons E1 (lacked in βe 
and β’e) and E4 (lacked in β’ and β’e) are sub-
ject to differential alternative splicing [18]. The 
regulation of alternative splicing may control 
the expression of actin-associated CaMKIIβ 
variants differently, thereby possibly affects 
the morphogenic functions of CaMKIIβ in den-
dritic arborization and/or synapse density. 
To better understand the underlying mecha-
nism, we investigated how CaMKIIβ variants 
interact with F-actin in E-18 cortical neurons. In 
previous study, a type of F-actin-rich structure 
in cortical neurons from embryonic day 18 
(E-18) rats was found and termed “Microspike” 
by our group [16, 17]. Scanning electron micros-
copy results revealed that these microspikes 
were composed of bundled actin filaments, and 
confocal imaging showed that WT CaMKIIβ 
strongly colocalized to this F-actin-rich struc-
ture. CaMKIIβ was found to be the only CaMKII 
isoform enriched in microspikes in E-18 neo-
cortex, where CaMKIIα was not detected until 
postnatal day 7 (P7). Meanwhile, cortical neu-
ron cultures expressed a detectable level of 
CaMKIIβ at 4 days in vitro (DIV), while CaMKIIα 
was not detected until 12 DIV [16, 17]. 
Therefore, this F-actin-rich structure, micro-
spike, provides a powerful system in developing 
neurons to further characterize the association 
of CaMKIIβ and its variants with F-actin without 
the disturbance of CaMKIIα isoform.
Materials and methods
Cell culture
Embryonic day 18 cortical neurons from preg-
nant Long Evans Rat were cultured as described 
by Redmond et al. [20]. 
Dissection: Cortices of embryonic day 18 
embryos were dissected from a sacrificed preg-
nant Long Evans rat (Charles River) and put in 1 
× ice-cold Hanks Balanced Salt Solution (HBSS; 
Invitrogen) while waiting for further treatment. 
All cortices were incubated in enzyme solution 
containing 10 units/ml of papain (Worthington 
Biochemical Corp.) and 0.16 mg/ml of 
L-cysteine (Sigma-Aldrich) for 40 minutes, the 
enzymatic reaction was then stopped by tryp-
sin inhibitor (Sigma).
Dissociation: Dissociation of cortical neurons 
was proceeded within BF media containing 
Basal Medium Eagle (Invitrogen), 1 mM L-glu- 
tamine (Invitrogen), 1 × Penicillin Streptomycin 
(Invitrogen), and 1% Fetal Bovine Serum (FBS; 
Invitrogen). Then dissociated cortical neurons 
were plated onto coverslips pre-coated by 20 
μg/ml of poly-D-lysine (BD Biosciences) and 1 
μg/ml of laminin (BD Biosciences). Cortical 
neurons were maintained in BNF media con-
taining BF and N2 supplement (Invitrogen) or 
serum-free media (FSM) consisting of Neuro- 
basal media (Invitrogen). After plated onto 
plates or dishes, the cortical neurons were cul-
tured in a humidified incubator at 37°C in a 5% 
CO2 environment for 5 days in vitro (DIV). Cell 
densities were 0.25 × 106 cells per well in 24 
well plates for immunostaining and 0.75 × 106 
cells per 35-mm glass-bottom dish (Mat Tek) 
for live cell imaging.
DNA constructs 
The green fluorescent protein (GFP)-tagged full-
length CaMKIIα, CaMKIIβ constructs (β, β’, βe, 
β’e) and GFP-actin used in this study were 
described by Lin et al. [16, 17].
Transfection
Cells were transfected with a modified calcium 
phosphate transfection procedure as described 
by Threadgill et al. [21]. Used culture medium 
was removed and saved 1 hr prior to transfec-
tion and replaced with Dulbecco’s Modified 
Eagle Medium (DMEM). The calcium phos-
phate/DNA precipitate was formed in HEPES 
buffered saline (pH 7.07) for 15-20 min when 
observed in light scattering. Then precipitate 
was added dropwise to neurons in DMEM. 
Following a 20-30 min transfection, during 
which a fine sandy precipitate covered the neu-
rons, the cultures were washed 3-4 times until 
the precipitate disappeared in DMEM and then 
returned to the saved original culture media. 
Transfection efficiency via this method was typ-
ically between 1% and 5%, and there was no 
apparent toxicity to the cells. As early as 12 hr 
posttransfection the product of transfected 
gene could be detected. 
Immunoblotting 
Respectively transfected cortical cultures were 
harvested at 5 DIV with lysis buffer containing 
TBS, 1% Triton X-100, 10% glycerol, 1-mM 
PMSF, 1-μg/ml leupeptin, and 500-μM Na3VO4 
on ice. Protein concentration was determined 
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Figure 2. Colocalization of CaMKIIβ variants with F-actin in microspikes. A. CaMKIIβ variants preferentially localized 
to F-actin-rich structures: Confocal images of E-18 cortical neurons at 4 DIV with mGFP tagged CaMKIIβ variants 
(green) and F-actin labeled with fluorescent conjugated phalloidin (red). Colocalization can be seen as yellow in the 
merged images. B. Enrichment of GFP-tagged proteins as indicated in microspikes (ratio of microspike/soma mean 
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by BCA assay. Of the total protein, 10 μg from 
each was loaded onto SDS/PAGE and trans-
ferred to nitrocellulose. Blots were incubated in 
blocking buffer as follows: 5% BSA in TBST 
(0.1% Triton X-100) at 4°C overnight (CaMKIIβ, 
1:1000). HRP-conjugated secondary antibod-
ies were diluted in blocking buffer and visual-
ized by chemiluminescence (Pierce). 
Immunocytochemistry
Cultured cortical neurons were fixed with 4% 
paraformaldehyde (PFA; J.T. Baker) and 4% 
sucrose (Sigma-Aldrich) in 1 × phosphate buf-
fer solution (PBS) for 15 min at room tempera-
ture at 5 DIV. Cultures were blocked with 3% 
bovine serum albumin (BSA; Fisher), 0.3% 
Triton X-100 (Sigma-Aldrich), 0.02% sodium 
azide (Sigma-Aldrich) in PBS for 2 hr at room 
temperature, then incubated with primary anti-
body GFP (1:1000; Molecular Probes), CaMKIIβ 
(1:250; Zymed) at 4°C overnight. F-actin was 
labeled with Alexa 488 or 568 conjugated phal-
loidin (1:25; Molecular Probes) to identify the 
microspike structures. Cell nuclei were stained 
with Hoechst. 25 × 75 mm glass micro slides 
(VWR) were used to mount coverslips with 
Aquamount (VWR) and sealed with fingernail 
polish. 
Images used to quantify microspike/soma ratio 
were acquired from at least 3 independent 
experiments by using an Axiovert200 Zeiss flu-
orescent microscope with 40 × (for cell counts) 
or 63 × (for ratio measurement) objective. The 
mean intensities of GFP in three randomly cho-
sen microspikes from one cell and the soma 
were measured and analyzed blind on GFP and 
phalloidin labeled cells with Improvision soft-
ware Openlab. The ratio was calculated by 
(mean intensity in the microspike)/(mean inten-
sity in the soma). The ratio values of three 
microspikes were averaged to generate one 
value per cell from 15-30 cells per construct.
Fluorescence recovery after photobleaching 
(FRAP)
E18 cortical neurons were cultured on 35-mm 
glass bottom dishes (MatTek) at 0.75 × 106 
cells/dish and imaged at 5 DIV. Before imaging, 
media was replaced with Culture External Base 
which containing 2-mM MgCl2, 2-mM CaCl2, 
150-mM NaCl, 2.5-mM KCl, 10-mM glucose, 
and 10-mM NaHEPES. Neurons were main-
tained in Culture External Base at room tem-
perature during imaging for a maximum time of 
two hours. Images were taken with a LSM- 
510Meta Zeiss confocal microscope by using 
63 × objective at 16 × zoom. Images were cap-
tured every 1 sec for 200 sec without any treat-
ment or 500 s when cells were incubated with 
10-μg/ml Cytochalasin D for 30 min or 1-μM Jaspla- 
kinolide for 1 hr before imaging to stabilize 
actin filaments.
A circular region of interest (ROI) with radius of 
0.43 μm was chosen for photobleaching. 
Neurons were photobleached after 10 frames 
of imaging with 10-12 iterations (20 iterations 
for GFP alone) of maximal excitation power. 
Background fluorescence, Fbkgd was deter-
mined in an unbleached area with similar initial 
fluorescence as the bleached ROI. F(t)ROI was 
normalized by background fluorescence with 
an equation of F(t)norm = (F(t)ROI/Fbkgd. The 
first time-point after the bleach was set to t = 0. 
The normalized fluorescence of the frame 
immediately before photobleaching, F(-1)norm, 
was set as 1. The fluorescence at other time 
points were normalized by F(-1)norm to gener-
ate the final fluorescence value, F(t)final = F(t)
norm/F(-1)norm. Final fluorescence was plot-
ted over time to generate the fluorescence 
recovery curve. When F(t)final reached 1, it was 
considered to have complete recovery. The 
50% recovery time was then determined by the 
time required to reach 50% of final recovered 
fluorescence, F1/2 = (F(∞)-F (0))/2. 
Statistical analysis
Data on all parameters were expressed as 
group mean ± SD. Differences between the 
experimental groups were analyzed by using 
the Student’s t-test. In all of the analyses, 
results were considered statistically significant 
when P < 0.05.
intensity) *P < 0.05; ***P < 0.001; compared with GFP-actin. ##P < 0.01; ###P < 0.001; compared with CaMKIIβ. 
@P < 0.05; compared with CaMKIIβ’. %P < 0.05; compared with CaMKIIβe. C. Microspikes-containing cells percent-
age of respectively transfected E-18 cortical neurons. **P < 0.01; ***P < 0.001; compared with GFP-actin. D. 
Western blot analysis of E-18 cortical neuronal culture lysates 5 DIV after mGFP tagged CaMKIIβ variants transfec-
tion (upper panel). Endogenous CaMKIIβ were identified in cultured E-18 cortical neurons (lower panel).
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Results
WT CaMKIIβ colocalized with the actin cyto-
skeleton stronger than the other variants
The mGFP fusion proteins of WT CaMKIIβ and 
its splice variants CaMKIIβ’, CaMKIIβe and 
CaMKIIβ’e were expressed in cultured E-18 cor-
tical neurons. Confocal images were taken at 4 
DIV to observe mGFP fusion proteins (green) 
and fluorescent conjugated phalloidin (red) 
labeled F-actin. Examples of transfected and 
immunostained cortical neurons were shown in 
Figure 2A. Colocalization can be seen as yellow 
in the merged images. 
No visible difference was observed between 
WT CaMKIIβ and the splice variants CaMKIIβ’, 
CaMKIIβe, and CaMKIIβ’e of their subcellular 
localization. All the three splice variants were 
observed mainly localized in the cytoplasm and 
processes, and displayed highly enriched colo-
calization with microspikes like WT CaMKIIβ as 
previously reported [16, 17]. No significant dif-
ferences among their colocalization patterns 
with microspikes in the E-18 cortical neurons 
could be determined with naked eyes through 
the microscope (Figure 2A).
To further quantitatively measure the F-actin 
colocalization of CaMKIIβ variants, we exam-
ined their subcellular localization by determin-
ing the enrichment (ratio of microspike/soma 
mean intensity) of these GFP-tagged variants in 
microspikes (Figure 2B). The enrichment of WT 
CaMKIIβ (2.03 ± 0.52) in microspikes was sig-
nificantly higher than all the three variants, β’ 
(1.63 ± 0.46), βe (1.58 ± 0.27) and β’e (1.34 ± 
0.30). The enrichment of WT CaMKIIβ in micro-
spikes happened where F-actin was enriched, 
indicated strong colocalization of WT CaMKIIβ 
with F-actin and suggested a specific interac-
tion between them. Although CaMKIIβ’, 
CaMKIIβe and CaMKIIβ’e were also localized to 
microspikes, they were significantly less 
enriched in the microspikes than WT CaMKIIβ. 
Among all the three variants, CaMKIIβ’e showed 
the lowest colocalization ratio with F-actin-
based-structure microspikes which close to the 
non-binding GFP control (data not shown), indi-
cating that CaMKIIβ’e had a very limited binding 
capacity with F-actin. Together, these data indi-
cated that WT CaMKIIβ had the strongest asso-
ciation with actin, whereas CaMKIIβ’e had the 
weakest.
Our previous results showed that the binding 
ability of CaMKIIβ to F-actin was important for 
the formation and maintenance of microspikes 
[16]. To establish whether alternative splicing 
of CaMKIIβ affects microspikes formation or 
stability, we investigated the prevalence of the 
microspikes in CaMKIIβ variants transfected 
E-18 cortical neurons by calculating the per-
centage of microspike-containing cells. Our 
results showed that 28.7 ± 5.0% WT CaMKIIβ 
transfected neurons contained microspikes, 
which was significantly less compared to the 
40.3 ± 4.8% of GFP-actin control transfected 
neurons (P < 0.05). However, no statistical sig-
nificance was observed among the percentag-
es of cells contained microspikes of WT 
CaMKIIβ and the other splice variants, β’ (25.1 
± 7.3%), βe (26.9 ± 3.6%) and β’e (24.0 ± 6.6%), 
although β had the highest percentage of 
microspike-containing cells than all the three 
variants (Figure 2C). Noticeablely, endogenous 
CaMKIIβ was co-expressed with the transfect-
ed GFP tagged CaMKIIβ variants in E-18 corti-
cal neurons (Figure 2D), thus the ability of 
endogenous CaMKIIβ binding to F-actin might 
affect the number of microspikes-containing 
cells and resulted in no significant difference 
between all CaMKIIβ variants.
CaMKIIβ variants were less mobile within E-18 
cortical neurons than CaMKIIα
Fluorescence recovery after photobleaching 
(FRAP) analysis technology was employed to 
further investigate the strength and dynamics 
of CaMKIIβ splice variants and actin interaction 
specifically in the microspikes of live E-18 corti-
cal neurons. A randomly selected single micro-
spike from each E-18 cortical neuron transfect-
ed with mGFP fusion CaMKIIβ variants was 
photobleached at 5 DIV. The microspikes in 
neurons transfected with CaMKIIα and GFP-
actin served as controls. Live cell images at 1 
sec before bleach (-1 sec), bleach (0 sec), and 
1, 5 and 30 sec after bleach (+ 1 sec, + 5 sec 
and + 30 sec, respectively) were chosen to rep-
resent the FRAP process (Figure 3A). 
Quantitative estimates of the association and 
dissociation rates of binding can be obtained 
from the FRAP [22-25]. 
The recorded intensities at each time point 
were calculated as described in methods and 
pulled together to generate the recovery curve 
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which reflected the molecular diffusion and 
binding dynamics. The recovery curve (Figure 
3B) demonstrated that the recovery of 
CaMKIIβ’, CaMKIIβe and CaMKIIβ’e were barely 
distinguishable from each other but were 
noticeably faster than WT CaMKIIβ. It was also 
found that the GFP-actin control group regained 
full recovery much slower than all the CaMKIIβ 
variants, and the non-binding CaMKIIα control 
showed the fastest recovery than all the other 
groups. 
Each group’s 50% recovery time was then cal-
culated to further assess the recovery efficien-
cy of each variants as well as controls (Figure 
3C). Among all groups, GFP-actin control pre-
sented a standard level of  how the actin fluo-
rescence intensity recovered in this F-actin-rich 
structure. The 50% recovery time of CaMKIIα 
(5.62 ± 1.74 sec) was significant longer (P < 
0.001) than all the CaMKIIβ variants and 
CaMKIIβ. CaMKIIα was the fastest to regain 
50% recovery of its original fluorescence inten-
sity at 0.96 ± 0.41 sec. This is consistent with 
previous reports that CaMKIIα did not directly 
bind to F-actin [15, 16, 26, 27] and conse-
quently more mobile than all CaMKIIβ variants 
within the E-18 cortical neurons. The 50% 
recovery time of WT CaMKIIβ (2.52 ± 1.09 sec) 
was almost two and half folds longer than non-
binding CaMKIIα, indicating that the mobility of 
WT CaMKIIβ was restricted by binding to F-acin 
within the microspikes as reported [16, 17]. 
The extended 50% recovery time in WT CaMKIIβ 
was revealed compared with variant CaMKIIβ’ 
(2.03 ± 0.77 sec), CaMKIIβe (1.75 ± 0.84 sec) 
and CaMKIIβ’e (1.50 ± 0.68 sec). Statistical sig-
nificances were identified between CaMKIIβ 
and CaMKIIβe (P < 0.01), CaMKIIβ and 
CaMKIIβ’e (P < 0.01). CaMKIIβ’ did not present 
any significant difference in 50% recovery time 
compare to CaMKIIβe and CaMKIIβ’e, although 
its 50% recovery time was longer. The slower 
recovery after photobleaching suggested the 
presence of a binding partner restricted the 
mobility of CaMKIIβ variants or controls. These 
results suggested that all CaMKIIβ variants dis-
played a stronger binding ability with F-actin 
than CaMKIIα, although not as strong as that of 
WT CaMKIIβ.
CaMKIIβ presented stronger association with 
immobilized F-actin than all other variants
The continuous dynamic of both CaMKIIβ and 
actin existed in live E-18 cortical neurons 
makes it complicated to understand the inter-
actions between them. Two drugs, Cytochalasin 
D and Jasplakinolide, were introduced to the 
system to inhibit actin movement. Cytochalasin 
D was reported to notably slow down but not 
completely prevent the recovery of actin, 
whereas Jasplakinolide completely immobilized 
actin, preventing any recovery of actin from 
photobleaching [16, 28]. With the immobilized 
actin within live E-18 cortical neurons, it is eas-
ier to explore as well as interpret the FRAP 
results of the CaMKIIβ variants, which may 
have potential interactions with actin. 
We sorted the Cytochalasin D or Jasplakinolide 
treated FRAP results of CaMKIIβ variants data 
together to build respective recovery curves 
(Figure 3D and 3F), and calculated their 50% 
recovery time (Figure 3E-G). GFP-actin group 
under respective drug treatments was set up 
as standard control for actin recovery rates. It 
presented significantly slower recovery com-
pared to all CaMKIIβ variants groups with either 
Cytochalasin D or Jasplakinolide treatment, 
which strongly indicated that there was signifi-
cant pool of CaMKIIβ variants which was not 
bound with the immobilized actin and remained 
mobile within the live cells. Because under 
either Cytochalasin D or Jasplakinolide, GFP-
actins never regained their 50% recovery, no 
50% recovery time result was shown for actin 
group in Figure 3E and 3G. CaMKIIβe and β’e 
recovery curves remained the same with either 
Cytochalisin D or Jasplakinolide treatment, and 
their 50% recovery time were significantly 
shorter compared to drug treated WT CaMKIIβ 
and CaMKIIβ’. These results indicated that the 
association of WT CaMKIIβ and CaMKIIβ’ with 
the F-actin were stronger than those of 
CaMKIIβe and CaMKIIβ’e. The FRAP recovery 
curve of WT CaMKIIβ and CaMKIIβ’ (Figure 3F) 
were separated with Jasplakionlide treatment 
but not with non-treatment nor with Cytochalisin 
D treatment (Figure 3B). Moreover, the 50% 
recovery time of WT CaMKIIβ (8.13 ± 3.09 sec) 
was almost one fold extended than CaMKIIβ’ 
(5.12 ± 1.74 sec) (Figure 3G), suggested that 
WT CaMKIIβ had stronger binding with F-actin 
than CaMKIIβ’.
WT CaMKIIβ displayed slower recovery with 
either Cytochalasin D or Jasplakinolide (Figure 
4A), suggesting that it had strong binding with 
F-actin and hence took longer time for the 
bound ones to disassociate from the immobi-
CaMKIIβ and F-actin in developing neurons
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Figure 3. FRAP results Recovery patterns of GFP-CaMKIIβ variants, GFP-CaMKIIα and GFP-actin from photobleaching. A. Live confocal images of GFP-CaMKIIβ vari-
ants transfected neuronsneuron before bleaching (-1 sec), at bleach time 0 sec, and + 1 sec, + 5 sec and + 30 sec after bleaching were shown as examples, as well 
as control group GFP-CaMKIIα and GFP-actin.  GFP tagged protein enriched areas can be seen as white pixels. Regions of interest (ROI) to be bleached were chosen 
from fluorescently intense areas (marked with yellow dashed circles). B. Fluorescence recovery curves of GFP-CaMKIIα, GFP-CaMKIIβ, β’, βe and β’e and GFP-actin 
without any treatment. C. Time required for the fluorescence of GFP-CaMKIIα, GFP-CaMKIIβ, β’, βe and β’e and GFP-actin to reache half-maximal recovery (50% 
recovery time). D. Fluorescence recovery patterns of GFP-CaMKIIα, GFP-CaMKIIβ, β’, βe and β’e and GFP-actin with Cytochalasin D treatment. E. 50% Recovery 
time of fluorescence of GFP-CaMKIIα, GFP-CaMKIIβ variants and GFP-actinafter Cytochalasin D treatment. F. Fluorescence recovery curves of GFP-CaMKIIα, GFP-
CaMKIIβ variants and GFP-actin with Jasplakinolide treatment. G. 50% Recovery time after Jasplakinolide treatment. ***p < 0.001; compared with GFP-actin. #P 
< 0.05; ##P < 0.01; ###P < 0.001; compared with CaMKIIβ. @@P < 0.01; @@@P < 0.001; compared with CaMKIIβ’. %%P < 0.01; %%%P < 0.001; compared with 
CaMKIIβe. &P < 0.05;  &&&P < 0.001; compared with CaMKIIβ’e.
CaMKIIβ and F-actin in developing neurons
2971 Int J Clin Exp Pathol 2014;7(6):2963-2975
Figure 4. Comparison of the effects with Cytochalasin D or Jasplakinolide treatment and without treatment in each GFP-CaMKIIβ variants groups, GFP-CaMKIIα and 
FPG-actin group. Fluorescence recovery patterns under non-treatment, with Cytochalasin D and Jasplakinolide treatment of WT CaMKIIβ (A), CaMKIIβ’ (B), CaMKIIβe 
(C) and CaMKIIβ’e (D), GFP-CaMKIIα (E) and GFP-actin (F). The recovery curves are shown on the left panels and the 50% recovery time plots are illustrated on the 
right. ***P < 0.001; compared with non-treatment. ##P < 0.01; ###P < 0.001; compared with under Cytochalasin D treatment. 
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lized actin. CaMKIIβ’ also displayed similar 
results (Figure 4B), although not as significant 
as WT CaMKIIβ. CaMKIIβe and CaMKIIβ’e did 
not show a difference between Jasplakinolide 
treatment and non-treatment control (Figure 
4C and 4D). Jasplakinolide was reported to 
completely immobilize the actin [28, 29], and 
our GFP-actin with Jasplakinolide treatment 
also displayed the same result as the actin did 
not recover at all (Figure 4E). The completely 
immobilized F-acin did not affect the recovery 
of CaMKIIβe and CaMKIIβ’e, which indicated 
that these two variants did not bind to F-actin, 
otherwise delayed recovery curve and extend-
ed 50% recovery time would be noticed, as dis-
covered in WT CaMKIIβ and CaMKIIβ’. GFP-
actin control displayed different recovery 
patterns for actin under Cytochalasin D or 
Jasplakinolide treatment (Figure 4F) which was 
consistent with previous reports [16, 28], and 
this might be responsible for the differences 
between Cytochalasin D and Jasplakinolide in 
most groups. Not surprisingly, non-binding con-
trol CaMKIIα also showed remarkable slow 
recovery curve when treated with Jasplakinolide 
(Figure 4E) as similar results were reported 
[16].
Discussion
Some previous studies examined F-actin and 
CaMKIIβ interactions in nonneuronal cells or in 
dendrite spines where endogenous CaMKIIα 
and CaMKIIβ were both expressed [13-15, 27]. 
F-actin was found to form thick bundled struc-
tures in vitro in the presence of the β-subunit of 
CaMKII but not in the presence of the α-subunit 
[15-17, 27, 30]. Protein structural studies indi-
cate that CaMKII is an oligomer composed of 
10-14 monomers arranged in rotational sym-
metry [31]. The CaMKIIα and β subunits coexist 
in neurons can associate and form hetero-
oligomers, which may bind simultaneously to 
different actin filaments through multiple 
β-subunits and, thus may confer on CaMKII 
with the ability to bundle actin filaments togeth-
er. In addition, CaMKIIα was addressed to have 
negative effect on CaMKIIβ and F-actin associ-
ation [16], and therefore might affect the relat-
ed binding outcomes. In this study, we per-
formed in vivo analyses of dynamic molecular 
interactions in rat E-18 cortical neurons to 
explore how alternative splicing in the variable 
domain of CaMKIIβ affects the actin colocaliza-
tion and association capability of CaMKIIβ vari-
ants in “microspikes”, a specific F-actin-rich 
structure previously identified and termed by 
our group [16, 17]. CaMKIIα was not expressed 
at the age examined, while CaMKIIβ strongly 
colocalized with F-actin within microspikes in 
E-18 cortical neurons [16]. Therefore, potential 
interactions between endogenous CaMKIIα 
and CaMKIIβ variants were eliminated and we 
can further explore the possible structural, 
rather than enzymatic, role of CaMKIIβ variants 
and their interactions with actin in developing 
neurons without the disturbance of CaMKIIα.
WT CaMKIIβ contains the exons E1, E3 and E4 
in its variable domain that CaMKIIα isoform 
doesn’t have. Correspondingly, WT CaMKIIβ but 
not CaMKIIα was proved to bind to F-actin [16]. 
Meanwhile, with the alternative splicing of 
exons E1 and E4 in the variable region, three 
CaMKIIβ variants, CaMKIIβ’, CaMKIIβe and 
CaMKIIβ’e, were produced in addition to WT 
CaMKIIβ [19]. The alternative splicing of 
CaMKIIβ mRNA is developmentally regulated 
and there appears to be a switch from the 
embryonic isoforms to the adult isoforms. In rat 
cortical neurons, CaMKIIβ and CaMKIIβ’ are 
the major expressed adult isoforms. CaMKIIβe 
and CaMKIIβ’e are embryonic isoforms 
expressed at high levels from birth until postna-
tal day 4 (P4) [19, 32, 33]. Notably, each of the 
new isoforms displayed identical protein kinase 
activity characteristic of WT CaMKIIβ (showed 
normal Ca2+/calmodulin-dependent phosphory-
lation of the specific CaMKII kinase) [19].
However, their kinase independent actin bind-
ing ability [16] had not been explored in cortical 
neurons yet. We hypothesized that alternative 
splicing of exons E1, E3 and/or E4 may be nec-
essary and serve as a developmental switch for 
the isoform-specific binding ability with F-actin, 
which plays an essential role in the process of 
neuronal maturation. Therefore, WT CaMKIIβ 
(contains E1, E3 and E4), CaMKIIβ’ (contains 
E1 and E3), CaMKIIβe (contains E3 and E4) as 
well as CaMKIIβ’e (contains E3 only) were inves-
tigated for their colocalization and association 
with microspikes in E-18 cortical neurons to 
determine the effect of alternative splicing in 
variable domain exons on their F-actin binding 
ability.
The measurement of CaMKIIβ varaints’ colocal-
ization with actin allowed us to evaluate the 
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respective binding ability in the fixed cells 
where both CaMKIIβ variants and actin were 
immobilized. In this condition, the intensity of 
colocalization should be consistent with the 
corresponding F-actin binding ability. The stron-
ger colocalization represents the stronger bind-
ing with F-actin. Both variants WT CaMKIIβ and 
CaMKIIβ’ containing E1 presented higher colo-
calization ratios than the other two non-E1 vari-
ants CaMKIIβe and CaMKIIβ’e, indicating that 
E1 is essential for CaMKIIβ association with 
F-actin.  The FRAP performed in live neurons 
allowed us to explore the interactions between 
CaMKIIβ variants and F-actin where both of 
them are dynamic. Furthermore, immobilization 
actin with drugs (Cytochalasin D or Jaspla- 
kinolide) helped us better understand the rela-
tive mobility and transferability of CaMKIIβ vari-
ants. If a molecule has a strong association 
with F-actin, it will take longer time for the 
bound ones to disassociate from the immobi-
lized actin after the diffusion of limited free 
molecules. Consistent with the colocalization 
data, the significantly slowed recovery of WT 
CaMKIIβ and CaMKIIβ’ after the drug treatment 
indicates that exon E1 is responsible for the 
significant pool of remained persistently bound 
to the immobilized F-actin. 
We noticed that all alternative splicing CaMKIIβ 
variants contain E3 yet they displayed signifi-
cant enrichment differences within the micro-
spikes. Besides, CaMKIIβ’e, which contains 
only E3, showed the lowest enrichment within 
F-actin rich microspikes. It suggested that pos-
sessing E3 alone was not enough for the asso-
ciation of CaMKIIβ variants with F-actin. The 
same conclusion can be drawn from the FRAP 
results of CaMKIIβ’e which showed a signifi-
cantly faster recovery than CaMKIIβ’ (contain-
ing E1 and E3) under either Cytochalasin D or 
Jasplakinolide treatment. 
CaMKIIβe, the dominant splice variant before 
birth [19], contains E4 in addition to E3. How- 
ever, no significant difference of colocalization 
with microspikes was identified between CaMK- 
IIβe and CaMKIIβ’e. FRAP recovery curves of 
CaMKIIβe and CaMKIIβ’e were almost identical 
to each other under all circumstances and no 
significant difference was observed for 50% 
recovery time between these two variants. 
These data indicated that E4 may not be suffi-
cient enough to target CaMKIIβe to F-actin 
either. However, CaMKIIβ’, which only lacks E4 
compare to WT CaMKIIβ, showed decreased 
colocalization within the microspikes, as well 
as faster FRAP recovery curve and significantly 
shorter 50% recovery time in most circum-
stances. These data referred that CaMKIIβ’ has 
decreased binding ability compared to WT 
CaMKIIβ, which suggested that the co-exis-
tence of E1 and E4 was needed for CaMKIIβ to 
better association with F-actin.
Interestingly, GFP-CaMKIIα also recovered 
more slowly from immobilized F-actin with drug 
treatments. Although we cannot rule out other 
mechanisms that may influence CaMKIIα mobil-
ity, the slowed recovery of GFP-CaMKIIα from 
immobilized F-actin is most likely due to 
CaMKIIα hetero-oligomerization via its associa-
tion domain with endogenous CaMKIIβ [34], 
which was reported to co-assemble with non-
actin binding isoforms and target such hetero-
meric holoenzymes to the actin cytoskeleton 
[26]. Oligomerization of CaMKIIβ, whether 
homo-oligomers or hetero-oligomers, is essen-
tial for actin binding, while monomeric CaMKIIβ 
can not bind to F-actin [35]. In CaMKIIα/β het-
ero-oligomers, the existence of CaMKIIα would 
decrease the ability of endogenous CaMKIIβ 
binding with F-actin [16], whereas homo-oligo-
mers CaMKIIβe and CaMKIIβ’e did not binding 
to the F-actin, and did not affect the endoge-
nous CaMKIIβ binding either. Therefore, 
CaMKIIβe and CaMKIIβ’e displayed slower 
recovery time than CaMKIIα. 
Briefly, our results are consistent with a previ-
ous report performed on Cos 7 cells in vitro 
[27]. These results together clearly indicated 
that in the E-18 cortical neurons in the absence 
of CaMKIIα, the variable region exon E1, which 
is lacked in CaMKIIβe and CaMKIIβ’e, is neces-
sary for localization of  actin cytoskeleton with-
in cells. CaMKIIβ’e containing only exon E3 in 
the variable region had no binding ability with 
F-actin. Meanwhile, since CaMKIIβe which con-
tains exon E4 only was not able to bind to 
F-actin, while the variant CaMKIIβ’ containing 
E1 only showed a decreased actin binding abil-
ity compared to WT CaMKIIβ, suggesting that 
E4 may help E1 better associate with F-actin. 
The actin cytoskeleton is remarkably dynamic 
and involved in many major cellular events such 
as LTP related synaptic plasticity [36], which 
may be differentially modulated via alternative 
splice of CaMKII isoforms with different actin 
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association abilities [12, 13, 15-17, 27]. Within 
living cells, there exsits a dynamic equilibrium 
between the monomeric form of globular-actin 
(G-actin) and the filamentous form of F-actin. It 
was reported that LTP could shift this F-actin/
G-actin equilibrium toward F-actin, suggesting 
that modification of the F-actin/G-actin equilib-
rium was required to trigger the morphological 
reorganization during LTP [4]. The resemblance 
between the F-actin-rich microspikes we 
explored in embryonic neurons and the new 
F-actin complex formed at the dendritic spine 
during LTP hints that these F-actin-rich cellular 
structures also serve both as a scaffold for the 
mechanical stability of spine structure and as a 
major docking site for postsynaptic proteins 
that directly and indirectly bind to F-actin as 
reported [37, 38]. This mechanism may be 
used to selectively captures the LTP-related 
proteins synthesized in the cell body and trans-
ported into dendrites [12]. In consideration that 
the binding ability of CaMKIIβ to F-actin was 
essential in mediating and regulating this 
F-actin-rich structure [16], The alternative splic-
ing of CaMKIIβ variants in developing neurons 
which lead to differences in actin binding ability 
may serve as a developmental switch for actin 
cytoskeleton-associated isoforms and there-
fore correlates with dendritic arborization and 
synapse formation during LTP.
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